Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 17.65% is in line with its 5-year average of 18.96%, around the middle of its 5-year range (12.86%–25.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.73% above its 12-month average of 17.02%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
17.65%
NET PROFIT MARGIN AVG TTM
17.02%
NET PROFIT MARGIN AVG 3Y
17.49%
NET PROFIT MARGIN AVG 5Y
18.96%
NET PROFIT MARGIN AVG 10Y
16.39%
NET PROFIT MARGIN AVG 15Y
13.13%
NET PROFIT MARGIN AVG 20Y
11.60%
CURRENT VS TTM AVG
+3.73%
CURRENT VS 3Y AVG
+0.93%
CURRENT VS 5Y AVG
-6.86%
CURRENT VS 10Y AVG
+7.74%
CURRENT VS 15Y AVG
+34.47%
CURRENT VS 20Y AVG
+52.18%
SECTOR MEDIAN · HEALTHCARE
8.91%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+98.14%
vs the sector median at left
West Pharmaceutical Services, Inc.
Market Cap
$24.73B
Net Profit Margin
17.65%
TTM Avg
17.02%
3Y Avg
17.49%
5Y Avg
18.96%
Market Cap
$24.54B
Net Profit Margin
27.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$24.03B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$26.21B
Net Profit Margin
9.19%
TTM Avg
8.91%
3Y Avg
9.15%
5Y Avg
11.71%
Market Cap
$26.44B
Net Profit Margin
6.99%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$21.88B
Net Profit Margin
41.56%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$29.04B
Net Profit Margin
21.91%
TTM Avg
21.94%
3Y Avg
21.74%
5Y Avg
21.20%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.73B | 17.65% | 17.02% | 17.49% | 18.96% |
| Incyte Corporation (INCY)vs › | $24.54B | 27.71% | 12.90% | 13.00% | 12.11% |
| Moderna, Inc. (MRNA)vs › | $24.03B | -141.43% | -128.24% | -70.25% | -50.87% |
| BioNTech SE (BNTX)vs › | $23.31B | -44.73% | -31.89% | 3.77% | 12.08% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.21B | 9.19% | 8.91% | 9.15% | 11.71% |
| STERIS plc (STE)vs › | $23.22B | 13.31% | 12.25% | 8.55% | 8.79% |
| Labcorp Holdings Inc. (LH)vs › | $26.44B | 6.99% | 6.01% | 6.56% | 9.24% |
| United Therapeutics Corporation (UTHR)vs › | $21.88B | 41.56% | 41.73% | 40.84% | 37.71% |
| Mettler-Toledo International Inc. (MTD)vs › | $29.04B | 21.91% | 21.94% | 21.74% | 21.20% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.60B | 16.82% | -1.96% | -34.26% | -68.70% |
Operating Margin
20.6%
Net Profit Margin
17.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 17.65% |
| 2026-03-31 | 16.43% |
| 2025-12-31 | 16.41% |
| 2025-09-30 | 17.41% |
| 2025-06-30 | 17.20% |
| 2025-03-31 | 12.86% |
| 2024-12-31 | 17.38% |
| 2024-09-30 | 18.21% |
| 2024-06-30 | 15.85% |
| 2024-03-31 | 16.58% |
| 2023-12-31 | 18.71% |
| 2023-09-30 | 21.58% |
| 2023-06-30 | 20.56% |
| 2023-03-31 | 19.56% |
| 2022-12-31 | 14.54% |
| 2022-09-30 | 17.57% |
| 2022-06-30 | 24.43% |
| 2022-03-31 | 24.15% |
| 2021-12-31 | 20.26% |
| 2021-09-30 | 24.85% |
| 2021-06-30 | 25.87% |
| 2021-03-31 | 22.53% |
| 2020-12-31 | 16.96% |
| 2020-09-30 | 15.01% |
| 2020-06-30 | 17.31% |
| 2020-03-31 | 15.12% |
| 2019-12-31 | 13.45% |
| 2019-09-30 | 12.35% |
| 2019-06-30 | 14.08% |
| 2019-03-31 | 12.50% |
| 2018-12-31 | 12.31% |
| 2018-09-30 | 12.79% |
| 2018-06-30 | 12.53% |
| 2018-03-31 | 10.48% |
| 2017-12-31 | -0.60% |
| 2017-09-30 | 12.79% |
| 2017-06-30 | 9.75% |
| 2017-03-31 | 15.70% |
| 2016-12-31 | 10.23% |
| 2016-09-30 | 9.98% |
| 2016-06-30 | 11.52% |
| 2016-03-31 | 6.10% |
| 2015-12-31 | 9.29% |
| 2015-09-30 | 0.44% |
| 2015-06-30 | 7.73% |
| 2015-03-31 | 9.79% |
| 2014-12-31 | 8.98% |
| 2014-09-30 | 8.71% |
| 2014-06-30 | 10.19% |
| 2014-03-31 | 7.81% |
| 2013-12-31 | 6.89% |
| 2013-09-30 | 7.84% |
| 2013-06-30 | 8.77% |
| 2013-03-31 | 9.34% |
| 2012-12-31 | 6.56% |
| 2012-09-30 | 4.87% |
| 2012-06-30 | 4.80% |
| 2012-03-31 | 9.23% |
| 2011-12-31 | 6.36% |
| 2011-09-30 | 5.76% |
| 2011-06-30 | 6.53% |
| 2011-03-31 | 6.64% |
| 2010-12-31 | 2.17% |
| 2010-09-30 | 6.56% |
| 2010-06-30 | 7.70% |
| 2010-03-31 | 7.21% |
| 2009-12-31 | 6.92% |
| 2009-09-30 | 6.64% |
| 2009-06-30 | 7.55% |
| 2009-03-31 | 6.35% |
| 2008-12-31 | 7.23% |
| 2008-09-30 | 5.19% |
| 2008-08-05 | 10.28% |
| 2008-03-31 | 9.68% |
| 2007-12-31 | 2.34% |
| 2007-09-30 | 5.03% |
| 2007-06-30 | 9.86% |
| 2007-03-31 | 10.29% |
| 2006-12-31 | 6.47% |
| 2006-09-30 | 6.09% |
| 2006-06-30 | 8.62% |
| 2006-03-31 | 8.12% |
| 2005-12-31 | 5.98% |
| 2005-09-30 | 4.30% |
| 2005-06-30 | 7.40% |
| 2005-03-31 | 8.90% |
| 2004-12-31 | 0.30% |
| 2004-09-30 | 3.18% |
| 2004-06-30 | 5.58% |
| 2004-03-31 | 5.24% |
| 2003-12-31 | 13.53% |
| 2003-09-30 | 3.41% |
| 2003-06-30 | 5.46% |
| 2003-03-31 | 3.23% |
| 2002-12-31 | 3.29% |
| 2002-09-30 | 3.43% |
